Synthesis of 3‐[4‐(1‐ethoxycarbonyl‐1‐methylethoxy)phenyl]‐5‐(3‐pyridyl)‐1,2,4‐[3‐14C]oxadiazole (AT‐308‐14C)
- 1 January 1978
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 14 (2) , 185-189
- https://doi.org/10.1002/jlcr.2580140205
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Biological studies of AT-308: Part 2. Hypocholesterolemic effect of AT-308, a new derivative of 1,2,4-oxadiazole, in ratsAtherosclerosis, 1973
- Biological studies of AT-308: Part 1. hypocholesterolemic effect of 1,2,4-oxadiazole derivatives in ratsAtherosclerosis, 1973
- Studies on the Syntheses of N-Heterocyclic Compounds. IV. Hypocholesterolemic 1, 2, 4-Oxadiazole Derivatives. (2)CHEMICAL & PHARMACEUTICAL BULLETIN, 1973
- Studies on the Synthese of N-Heterocyclic Compounds. III. Hypocholesterolemic 1, 2, 4-Oxadiazole Derivatives (1)CHEMICAL & PHARMACEUTICAL BULLETIN, 1973
- Effects of α-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liverJournal of Lipid Research, 1965
- EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER1965
- Modification of Metabolism and Distribution of Lipids by Ethyl ChlorophenoxyisobutyrateNature, 1962